Transcatheter closure of patent ductus arteriosus using the AMPLATZER™ duct occluder II (ADO II)

Transcatheter closure of patent ductus arteriosus using the AMPLATZER™ duct occluder II (ADO II)

Objectives The study purpose is to evaluate the safety and efficacy of the ADO II device for closure of patent ductus arteriosus (PDA) in children. Background Transcatheter treatment of PDA has been evolving for 40+ years and is the treatment of choice. The AMPLATZER™ Duct Occluder (ADO) device was...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Catheterization and cardiovascular interventions 2017-05, Vol.89 (6), p.1118-1128
Hauptverfasser: Gruenstein, Daniel H., Ebeid, Makram, Radtke, Wolfgang, Moore, Phillip, Holzer, Ralf, Justino, Henri
Format: Artikel
Sprache:eng
Schlagworte:
Adolescent
AMPLATZER™ duct occluders
Aorta
Aortic arch
Aortography
Cardiac Catheterization - adverse effects
Cardiac Catheterization - instrumentation
Catheterization
Catheters
Child
Child, Preschool
Children
Congenital diseases
Coronary vessels
Ductus Arteriosus, Patent - diagnostic imaging
Ductus Arteriosus, Patent - physiopathology
Ductus Arteriosus, Patent - therapy
Female
Fluoroscopy
Hemodynamics
Humans
Implantation
Infant
Male
occluder
patent ductus arteriosus
Pressure gradients
Prospective Studies
Prosthesis Design
Pulmonary arteries
Pulmonary artery
Radiation
Radiation Dosage
Radiation Exposure - prevention & control
Risk Factors
Septal Occluder Device
Statistical analysis
Time Factors
transcatheter closure
Treatment Outcome
United States
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objectives The study purpose is to evaluate the safety and efficacy of the ADO II device for closure of patent ductus arteriosus (PDA) in children. Background Transcatheter treatment of PDA has been evolving for 40+ years and is the treatment of choice. The AMPLATZER™ Duct Occluder (ADO) device was developed for larger diameter ducts and is not ideal in all PDAs. ADO II was developed for small to moderate‐sized ducts. Methods This is a single‐arm, multicenter study evaluating safety and efficacy of the ADO II device. Patients
ISSN:1522-1946
1522-726X
DOI:10.1002/ccd.26968